During the last session, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s traded shares were 659.28 million, with the beta value of the company hitting 2.18. At the
In the last trading session, 10.23 million shares of the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) were traded, and its beta was 2.15. Most recently the
In the last trading session, 7.35 million Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares changed hands as the company’s beta touched 2.15. With the company’s per
In the last trading session, 6.59 million Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares changed hands as the company’s beta touched 2.15. With the company’s per
In last trading session, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) saw 9.91 million shares changing hands with its beta currently measuring 2.15. Company’s recent per share
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has a beta value of 2.08 and has seen 11.51 million shares traded in the last trading session. The company,
During the last session, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s traded shares were 14.34 million, with the beta value of the company hitting 2.09. The 52-week
In the last trading session, 15.54 million shares of the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) were traded, and its beta was 2.09. Most recently the
In today’s recent session, 9.05 million shares of the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have been traded, and its beta is 2.09. Most recently the
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s traded shares stood at 11.99 million during the last session, with the company’s beta value hitting 2.09. At the close
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
